Literature DB >> 17137730

Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer.

Enio Ferreira1, Alessandra Estrela da Silva, Rogéria Serakides, Mardelene Geisa Gomes, Geovanni Dantas Cassali.   

Abstract

This study used Ehrlich solid tumor as an experimental model for breast cancer to investigate the effects of thyroid hormones and castration on tumor development in adult female mice. Artificial hyperthyroidism was induced in animals, and after a 30-day-treatment, they received subcutaneous injection of neoplastic cells between left plantar cushions. We measured the growth of tumor inoculated in the paws for 10 days at necropsy. Hyperthyroidism induction led to significantly increased tumor size in non-castrated animals, and alterations were less intense in association with artificial hyperthyroidism and castration (p<0.05). Histomorphologic and histomorphometric analyses and neoplastic cell characterization were carried out by measuring nuclear diameter, by evaluating AgNORs, by mitotic count, and by measuring cell proliferation using immunohistochemical marker CDC47. At the end of the experiment, we noted metabolism and a decrease in cell proliferation in groups having received l-thyroxine, which were more evident in the non-castrated group (p<0.001).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137730     DOI: 10.1016/j.prp.2006.09.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Antioxidant activities of α-lipoic acid free and nano-capsule inhibit the growth of Ehrlich carcinoma.

Authors:  Monira M Rageh; Reem H El-Gebaly
Journal:  Mol Biol Rep       Date:  2019-04-01       Impact factor: 2.316

2.  Efficacy of protocols for induction of chronic hyperthyroidism in male and female mice.

Authors:  Kathrin Engels; Helena Rakov; Denise Zwanziger; Georg Sebastian Hönes; Maren Rehders; Klaudia Brix; Josef Köhrle; Lars Christian Möller; Dagmar Führer
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

Review 3.  Insight Into Mouse Models of Hyperthyroidism.

Authors:  Mengyu Zhang; Wen Jiang; Ganghua Lu; Ru Wang; Zhongwei Lv; Dan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

4.  A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer.

Authors:  Noha Khalifa Abo Aasy; Doaa Ragab; Marwa Ahmed Sallam; Doaa A Abdelmonsif; Rania G Aly; Kadria A Elkhodairy
Journal:  Int J Nanomedicine       Date:  2019-09-17

5.  Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.

Authors:  Sabine Heublein; Doris Mayr; Alfons Meindl; Martin Angele; Julia Gallwas; Udo Jeschke; Nina Ditsch
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 6.  Thyroid Diseases and Breast Cancer.

Authors:  Enke Baldini; Augusto Lauro; Domenico Tripodi; Daniele Pironi; Maria Ida Amabile; Iulia Catalina Ferent; Eleonora Lori; Federica Gagliardi; Maria Irene Bellini; Flavio Forte; Patrizia Pacini; Vito Cantisani; Vito D'Andrea; Salvatore Sorrenti; Salvatore Ulisse
Journal:  J Pers Med       Date:  2022-01-25

7.  Alfa-lipoic acid controls tumor growth and modulates hepatic redox state in Ehrlich-ascites-carcinoma-bearing mice.

Authors:  M Al Abdan
Journal:  ScientificWorldJournal       Date:  2012-05-01

8.  Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).

Authors:  Mohammad M Abd-Alhaseeb; Sawsan A Zaitone; Soad H Abou-El-Ela; Yasser M Moustafa
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.